A yogurt label promising to โsupport digestive healthโ rests on more science than it looks. Food companies now borrow drug-trial rigor to back these claims, but the evidence only covers one ingredient, at one specific dose.
Borrowing Rigor From Pharma
Food developers increasingly lean on methods once reserved for medicine. The gold standard is the randomized controlled trial, where people get either the real ingredient or a placebo so researchers can measure the true effect.
Legal experts reviewing food claim rules put it plainly: substantiation of health-related benefits generally needs randomized, controlled human clinical testing.
A single company-funded study carries little weight until other researchers can reproduce the same result. That migration of drug-grade scrutiny into the cereal and yogurt aisles is why some labels now read more like footnotes than slogans.
Matching Dose To Servings
A benefit proven in a lab means little if a normal serving canโt deliver it. Researchers ask whether one ordinary bowl or cup actually contains the amount that worked in the trial.
Often it doesnโt. When that gap shows up, companies reformulate to concentrate the ingredient, fortify the product, or soften the claim to match what a real portion delivers.
One four-year trial of 2,303 healthy women found that calcium and vitamin D supplementation did not reduce the risk of cancer overall, a reminder that a plausible idea still has to survive the numbers. A trustworthy claim has already passed the test of an actual mealtime portion.
